Celcuity (CELC) Change in Account Payables (2016 - 2025)
Celcuity (CELC) posted Change in Account Payables of -$4.8 million for Q4 2025, down 8672.73% on a QoQ basis from -$55000.0 in Q3 2025, and down 2273.42% year-over-year from $222000.0 in Q4 2024.
Celcuity (CELC) Change in Account Payables (2016 - 2025) Analysis & Trends
Celcuity's Change in Account Payables history runs 10 years deep, the most recent figure standing at -$4.8 million for Q4 2025.
- Quarterly Change in Account Payables fell 2273.42% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.0 million (down 170.44% YoY) and the FY2025 annual result came in at -$3.0 million, down 170.44% from the prior year.
- Change in Account Payables was -$4.8 million for Q4 2025 at Celcuity, down from -$55000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.9 million in Q3 2024 and bottomed at -$4.8 million in Q4 2025.
- A 5-year average of $304481.3 and a median of $301047.0 in 2021 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 19904.03% — and 2025, when it tumbled 2273.42%.
- Celcuity's Change in Account Payables stood at -$247449.0 in 2021, then slumped by 92.4% to -$476096.0 in 2022, then decreased by 26.3% to -$601309.0 in 2023, then surged by 136.92% to $222000.0 in 2024, then tumbled by 2273.42% to -$4.8 million in 2025.
- Business Quant data shows CELC's Change in Account Payables at -$4.8 million in Q4 2025, -$55000.0 in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | -4.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.83 Mn |
| Dec 31, 2025 | -4.83 Mn |
| Sep 30, 2025 | -55,000.00 |
| Sep 30, 2025 | -55,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 613,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 945,000.00 |
| Jun 30, 2024 | 945,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Dec 31, 2023 | -601,309.00 |
| Dec 31, 2023 | -601,309.00 |
| Sep 30, 2023 | 2.61 Mn |
| Sep 30, 2023 | 2.61 Mn |